GW Pharmaceuticals plc (LON:GWP) insider Tom Lynch sold 2,074 shares of GW Pharmaceuticals plc stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of GBX 790 ($9.79), for a total transaction of £16,384.60 ($20,295.55).

GW Pharmaceuticals plc (LON:GWP) opened at 847.9152 on Monday. The firm has a 50-day moving average of GBX 823.04 and a 200 day moving average of GBX 614.46. The stock’s market capitalization is GBX 2.23 billion. GW Pharmaceuticals plc has a 12-month low of GBX 211.00 and a 12-month high of GBX 950.00.

Insider Buying and Selling by Quarter for GW Pharmaceuticals plc (LON:GWP)

Separately, Numis Securities Ltd reissued a “hold” rating and set a GBX 545 ($6.75) price objective on shares of GW Pharmaceuticals plc in a report on Friday, August 26th.

GW Pharmaceuticals plc Company Profile

GW Pharmaceuticals plc is involved in the development of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant. The Company develops a portfolio of cannabinoid medicines, including Epidiolex, which is an oral medicine for the treatment of refractory childhood epilepsies.

Receive News & Stock Ratings for GW Pharmaceuticals plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GW Pharmaceuticals plc and related stocks with our FREE daily email newsletter.